Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:CLIGFOTCMKTS:CYGIYOTCMKTS:RPCGFOTCMKTS:SAPMF On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCLIGFClinigen Group$8.02$8.02$8.02▼$11.56$1.07B0.498,620 shsN/ACYGIYCyberAgent$3.70$3.98$2.88▼$4.47$3.75B0.461,029 shsN/ARPCGFRPC Group$10.40$10.40$8.45▼$10.85$4.24B0.211,775 shsN/ASAPMFSaipem$2.33-0.2%$2.14$1.81▼$2.84$4.64B1.111,672 shs430 shs7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCLIGFClinigen Group0.00%0.00%0.00%0.00%0.00%CYGIYCyberAgent0.00%-11.27%-11.48%+1.93%+2.78%RPCGFRPC Group0.00%0.00%0.00%0.00%0.00%SAPMFSaipem-0.21%+10.08%-1.90%-5.87%+1.97%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCLIGFClinigen GroupN/AN/AN/AN/AN/AN/AN/AN/ACYGIYCyberAgentN/AN/AN/AN/AN/AN/AN/AN/ARPCGFRPC GroupN/AN/AN/AN/AN/AN/AN/AN/ASAPMFSaipemN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCLIGFClinigen Group 0.00N/AN/AN/ACYGIYCyberAgent 0.00N/AN/AN/ARPCGFRPC Group 0.00N/AN/AN/ASAPMFSaipem 4.00Strong BuyN/AN/ACurrent Analyst Ratings BreakdownLatest CLIGF, RPCGF, CYGIY, and SAPMF Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails2/28/2025SAPMFSaipemKepler Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold ➝ Strong-Buy(Data available from 4/30/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCLIGFClinigen Group$704.71M1.51$1.43 per share5.60$4.52 per share1.77CYGIYCyberAgent$5.61B0.67$0.24 per share15.19$1.64 per share2.26RPCGFRPC Group$4.97B0.85$1.67 per share6.23$6.25 per share1.66SAPMFSaipem$12.88B0.36$0.12 per share19.34N/A∞Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCLIGFClinigen Group$40.78MN/A0.00∞N/AN/AN/AN/AN/ACYGIYCyberAgent$108.86M$0.1230.8421.76N/A2.67%11.56%5.63%4/30/2025 (Estimated)RPCGFRPC Group$336.18MN/A0.00∞N/AN/AN/AN/AN/ASAPMFSaipem$200.21MN/A0.00∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCLIGFClinigen GroupN/AN/AN/AN/AN/ACYGIYCyberAgent$0.061.62%N/A50.00%N/ARPCGFRPC GroupN/AN/AN/AN/AN/ASAPMFSaipemN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCLIGFClinigen GroupN/AN/AN/ACYGIYCyberAgent0.352.142.08RPCGFRPC GroupN/AN/AN/ASAPMFSaipemN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCLIGFClinigen GroupN/ACYGIYCyberAgentN/ARPCGFRPC GroupN/ASAPMFSaipemN/AInsider OwnershipCompanyInsider OwnershipCLIGFClinigen GroupN/ACYGIYCyberAgentN/ARPCGFRPC GroupN/ASAPMFSaipemN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCLIGFClinigen Group1,069133.03 millionN/ANot OptionableCYGIYCyberAgent7,2511.01 billionN/ANot OptionableRPCGFRPC Group24,868407.39 millionN/ANot OptionableSAPMFSaipem32,0002.00 billionN/ANot OptionableCLIGF, RPCGF, CYGIY, and SAPMF HeadlinesRecent News About These CompaniesSaipem secures €520m contract for Liverpool Bay CCS project in UKApril 29 at 10:14 PM | msn.comSaipem, contratto da 520 milioni da Eni per cattura Co2 in UkApril 29 at 12:02 PM | msn.comSaipem awarded contract by Eni for Liverpool Bay CCS projectApril 29 at 1:56 AM | chemengonline.comSaipem awarded contract by Eni for Liverpool Bay CCS projectApril 29 at 1:56 AM | chemengonline.comSaipem, contratto da Eni nel Regno UnitoApril 28 at 10:12 AM | it.investing.comSaipem câștigă contractul Eni de captare și stocare a carbonului de 520 de milioane de dolari în Marea BritanieApril 28 at 10:12 AM | firstonline.infoStifel upgrades Saipem to “buy,” citing strong Q1 results and favorable outlookApril 28 at 10:12 AM | in.investing.comSaipem wins Eni's $520M carbon capture and storage contract in the UKApril 28 at 10:12 AM | firstonline.infoSaipem, contratto da Eni per cattura e stoccaggio carbonio nel Regno UnitoApril 28 at 5:10 AM | teleborsa.itSaipem ottiene contratto da 520 milioni per progetto di cattura Co2 nel Regno UnitoApril 28 at 5:10 AM | msn.comSaipem in rialzo, analisti positivi sull'accordo con EniApril 28 at 5:10 AM | ilsole24ore.comSaipem, nuovo contratto da ENIApril 28 at 5:10 AM | soldionline.itSaipem si aggiudica un maxi contratto nel Regno Unito: ecco di cosa si occuperà. Stifel alza il giudizioApril 28 at 5:10 AM | milanofinanza.itSaipem wins €520m contract on Eni’s Liverpool Bay CCS projectApril 28 at 5:10 AM | gastopowerjournal.comSaipem secures new contract for CCS projectApril 28 at 5:10 AM | en.trend.azSaipem SpA (SPEA) Receives a Buy from Kepler CapitalApril 28 at 5:10 AM | markets.businessinsider.comSaipem Gets On Bard Eni’s Liverpool Bay CCS ProjectApril 28 at 5:10 AM | oedigital.comRBC Capital Remains a Buy on Saipem SpA (SPEA)April 26, 2025 | markets.businessinsider.comSaipem vola nel primo trimestre. Ricavi a +12%, utile a 57 mlnApril 26, 2025 | informazione.itSaipem, im ersten Quartal: Gewinn +35 %, Umsatz +15,5 %, Bestellungen über 2 Milliarden. Prognose für 2025 bestätigtApril 25, 2025 | msn.comShort Interest in Saipem SpA (OTCMKTS:SAPMF) Expands By 30.5%April 21, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCLIGF, RPCGF, CYGIY, and SAPMF Company DescriptionsClinigen Group OTCMKTS:CLIGF$8.02 0.00 (0.00%) As of 03/24/2023Clinigen Group plc operates as a pharmaceutical and services company in the United Kingdom, rest of Europe, the United States, South Africa, Australia, and internationally. It operates through Services and Products divisions. The company provides a set of niche and high value services to pharma and biotech clients prior to product launch. It also provides access to critical medicines around the world for patients with unmet needs. In addition, the company provides a portfolio of specialist medicines to service the needs of healthcare professionals and their patients in both licensed and unlicensed markets. Further, it offers Nortriptyline Colonis for the treatment of depressive disorder; Metformin Colonis for the treatment of type 2 diabetes mellitus; Magnesium Chewable Tablets, an oral magnesium supplements for the treatment of patients with chronic magnesium loss; Iloprost, a concentrate for solution for infusion; Glycopyrronium Bromide, an oral solution for the treatment of severe sialorrhoea; Acetylcysteine, an oral solution for the treatment of respiratory disorders associated with thick, viscous, and mucus hypersecretion; Cardioxane that protects the heart against the cardiotoxic effects of anthracyclines; Ethyol, which protect against the harmful effects of chemotherapy medications and radiation treatment; Proleukin for the treatment of kidney cancer; Imukin that is used in chronic granulomatous disease; Totect, a dexrazoxane product; Foscavir, an anti-virals that work by stopping viruses from multiplying in number; and Savene, which is indicated in adults for the treatment of anthracycline extravasation. The company was incorporated in 2008 and is headquartered in Burton-on-Trent, the United Kingdom.CyberAgent OTCMKTS:CYGIY$3.70 0.00 (0.00%) As of 04/29/2025CyberAgent, Inc. engages in the media, internet advertising, game, and investment development businesses primarily in Japan. The company operates Ameba, a blog service; Tapple for online dating; AWA, a music streaming service; and WinTicket for online betting. It also offers internet advertising agency and ad technology services; and smartphone games. In addition, the company operates a programming school for kids and provides application and reward points exchange platform services; artificial intelligence services; and digital transformation services. CyberAgent, Inc. was incorporated in 1998 and is headquartered in Tokyo, Japan.RPC Group OTCMKTS:RPCGF$10.40 0.00 (0.00%) As of 07/2/2019RPC Group Plc operates as a plastic product design and engineering company worldwide. It operates through two segments, Packaging and Non-Packaging. The Packaging segment designs plastic packaging for end markets, including the food, beverage, personal care, and healthcare markets; and designs and manufactures other plastic products, such as containers for surface coatings comprising paint pots and vaping accessories. It sells its products directly to the brands, as well as to retailers or fillers. The Non-Packaging segment designs and manufactures a range of plastic products that include temporary storage systems for waste and recycling; and technical components for the automotive and heavy vehicles industries. It also makes moulds, which are used to make plastic components and packaging products. This segment sells its products to intermediaries. The company was founded in 1991 and is headquartered in Rushden, the United Kingdom.Saipem OTCMKTS:SAPMF$2.33 -0.01 (-0.21%) As of 04/29/2025 01:06 PM EasternSaipem SpA provides energy and infrastructure solutions worldwide. The company operates through Asset Based Services, Offshore Drilling, and Energy Carriers segments. It offers development of subsea fields and pipelaying; installation and lifting of offshore structures; and engineering, implementation, installation, maintenance, modification, and decommissioning activities. The company also engages in onshore engineering and construction, sustainable infrastructures, and robotics and industrialized solutions; and offshore engineering and construction, and wind activities. In addition, the company provides procurement, construction, project management, and engineering integrated services to the oil and gas, civil and marine infrastructure, and environmental markets. Saipem S.p.A. was founded in 1957 and is headquartered in Milan, Italy. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Hims & Hers Stock Soars on Novo Nordisk Collaboration 3 Dividend Kings Outshining the Market in 2025 Tesla's Band-Aid Has Been Ripped Off: Rally Mode Engaged Amazon's Earnings Will Make or Break the Stock's Comeback Why D-Wave's Project With Davidson Is a Game-Changer For Quantum NXP Semiconductors: A Buy-and-Hold Stock in the Buy Zone Joby Aviation Shares Eye Breakout After Transition Flight Win Altria’s Resilient Strategy Keeps It a Top Dividend Play in 2025 Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
